Are you a Healthcare Professional?
This section of the AMITIZA website is for healthcare professionals only.
You may experience side effects when taking AMITIZA. Tell your doctor about any side effects you have. Below are the most common side effects of AMITIZA for each type of chronic constipation that AMITIZA treats.
See the Prescribing Information for a complete list of side effects.
For Chronic Idiopathic Constipation (CIC), the most common side effects of AMITIZA (24 mcg twice daily) are:
While these aren't all the side effects of AMITIZA, your doctor or pharmacist can give you a more complete list. You can also see the complete Prescribing Information.
For Opioid-Induced Constipation (OIC), the most common side effects of AMITIZA (24 mcg twice daily) are:
While these aren't all the side effects of AMITIZA, your doctor or pharmacist can give you a more complete list. You can also see the complete Prescribing Information.
For Irritable Bowel Syndrome with Constipation (IBS-C), the most common side effects of AMITIZA (8 mcg twice daily) are:
While these aren't all the side effects of AMITIZA, your doctor or pharmacist can give you a more complete list. You can also see the complete Prescribing Information.
Pay as little as $0* every month for your prescription PLUS get tips and information about managing chronic constipation.
*Subject to maximum benefit.
You must meet Eligibility Requirements.
Find out what real patients have to say about their experience with chronic constipation and AMITIZA.
These guides can help you prepare for your next doctor visit and track how you're doing with AMITIZA.
AMITIZA is used for 3 types of chronic constipation: CIC in adults, OIC in adults with chronic pain that is not caused by active cancer, and IBS-C in women ≥ 18 years. Effectiveness in patients taking methadone has not been established.
AMITIZA (lubiprostone) is not for everyone. If you know or suspect you have a bowel blockage, do not take AMITIZA. If you are unsure, your healthcare provider (HCP) should evaluate your condition before starting AMITIZA.
Some patients taking AMITIZA may experience nausea. Take AMITIZA with food and water to reduce the occurrence of nausea.
Do not take AMITIZA if you have severe diarrhea. Some patients taking AMITIZA may experience diarrhea. If your diarrhea becomes severe, stop taking AMITIZA and tell your HCP.
Patients may experience fainting and low blood pressure after taking the first dose or repeated doses of AMITIZA. Stop taking AMITIZA and tell your HCP if these reactions occur. Symptoms usually go away before the next dose but may recur with repeated use. Tell your HCP if you are taking any medications to lower blood pressure. Other side effects such as diarrhea or vomiting may increase the risk of fainting and low blood pressure.
Within an hour of taking AMITIZA, a sensation of chest tightness and shortness of breath may occur. These symptoms usually go away within three hours, but may recur with repeated use. Tell your HCP if you experience these symptoms.
The most common side effects of taking AMITIZA 24 mcg twice daily for CIC are nausea, diarrhea, headache, abdominal pain, abdominal distension, and gas. The most common side effects of taking AMITIZA 24 mcg twice daily for Opioid-Induced Constipation are nausea and diarrhea. The most common side effects of taking AMITIZA 8 mcg twice daily for IBS-C are nausea, diarrhea, and abdominal pain. These are not all the side effects associated with AMITIZA.
Tell your HCP if you are taking a diphenylheptane opioid (e.g., methadone).
AMITIZA has not been studied in pregnant women. Based on animal studies, AMITIZA may cause fetal harm. AMITIZA should only be used during pregnancy if the potential benefits justify the potential risk to the fetus. If you are pregnant or become pregnant while being treated with AMITIZA, talk to your HCP to evaluate the risks to the fetus. Tell your HCP if you are nursing and monitor infants for diarrhea.
Tell your HCP if you have liver problems.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
AMITIZA (lubiprostone) 24 mcg capsules twice daily is approved to treat Chronic Idiopathic Constipation (CIC) in adults. “Idiopathic” means the cause of the constipation is unknown and not due to an underlying illness or medication. AMITIZA 24 mcg twice daily is also approved to treat constipation caused by opioids, a type of prescription pain medicine, in adults with chronic pain that is not caused by active cancer. The effectiveness of AMITIZA has not been established if you are taking a diphenylheptane opioid (e.g., methadone). AMITIZA 8 mcg capsules twice daily is approved to treat Irritable Bowel Syndrome with Constipation (IBS-C) in women ≥ 18 years of age.
Please click here for complete Prescribing Information.
